ANA5 Funnel Catheter System
Acute Ischemic Stroke due to Large Vessel Occlusion (Mechanical Thrombectomy)
Commercial (EU); Investigational (US)Active
Key Facts
Indication
Acute Ischemic Stroke due to Large Vessel Occlusion (Mechanical Thrombectomy)
Phase
Commercial (EU); Investigational (US)
Status
Active
Company
About Anaconda BioMed
Anaconda Biomed is a Spanish medical device innovator developing the ANA thrombectomy system, a novel catheter designed to improve the safety and efficacy of mechanical thrombectomy for stroke. Its core technology features a self-expanding, flow-restricting nitinol funnel that aims to reduce clot fragmentation and embolization during retrieval. The company's lead product, the ANA5 Funnel Catheter, has CE mark approval in Europe and is in the investigational stage in the United States, positioning it in the high-growth neurovascular intervention market.
View full company profile